Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Barnaby Pickering

Senior Writer

London, UK

Barnaby lives and works in Yorkshire. Having graduated from University College London with a master's degree in biomedical engineering in 2020, Barnaby is passionate about cutting-edge medical technology. Key areas of focus for Barnaby include diabetes, nanotechnology, machine learning and artificial intelligence.

Latest From Barnaby Pickering

Chapter 11 Bankruptcy, Not A Party You Would Want An Invitae For

Less than a month after it sold off its reproductive health assets, Invitae has filed for bankruptcy. That will not come as a surprise to anyone following the company.

Medical Device Commercial

Freenome Bags Another $254m As Study Results Draw Closer

Freenome, the Roche-backed early cancer detection liquid biopsy developer has raised yet more money, making it one of the best-funded companies in its sub-sector. With trial results due relatively soon, investors are likely hoping this will be the last funding round required before full commercialization.

Diagnostics Cancer

Surgical VR May Look Like Fun, But It Is No Game For Osso’s CEO

Osso VR’s platform for the simulation of orthopedic surgical procedures could solve several issues facing the field, according to CEO Justin Barad.

Exec Chats Medical Device

Diagnostics CEOs In Triplicate Weigh In On Upcoming Hurdles

Tune in to this one-off podcast feature discussing the state-of-play in the diagnostics sector, with guests from ImmunExpress, Lucid Diagnostics and ChromaCode. 

Blood & Coagulation Disorders Diagnostics

Diagnostics CEOs In Triplicate Weigh In On Upcoming Hurdles

Tune in to this one-off podcast feature discussing the state-of-play in the diagnostics sector, with guests from ImmunExpress, Lucid Diagnostics and ChromaCode. 

Blood & Coagulation Disorders Diagnostics

Cardio Catch-Up: Procyrion Raises Nearly $60M As Aortix Creeps Closer To Clinic

The Houston-based cardiovascular device developer has secured renewed support from its investors to fund its pivotal trial of Aortix, a device designed to treat patients suffering from often-fatal, difficult to treat cardiorenal syndrome.

Financing Cardiology
See All
UsernamePublicRestriction

Register